# Comparison of Two Basal Insulins for Patients With Type 2 Diabetes Taking Oral Diabetes Medicines and Exenatide

> **NCT00560417** · PHASE3 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 339 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** Insulin Lispro Protamine Suspension
- **DRUG:** Insulin Glargine

## Key facts

- **NCT ID:** NCT00560417
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-11
- **Primary completion:** 2009-12
- **Final completion:** 2009-12
- **Target enrollment:** 339 (ACTUAL)
- **Last updated:** 2011-01-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00560417

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00560417, "Comparison of Two Basal Insulins for Patients With Type 2 Diabetes Taking Oral Diabetes Medicines and Exenatide". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00560417. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*